publicações selecionadas
-
artigo de revista
- Brachyury as a potential modulator of androgen receptor activity and a key player in therapy resistance in prostate cancer.. Oncotarget. 2016
- A glycolytic phenotype is associated with prostate cancer progression and aggressiveness: a role for monocarboxylate transporters as metabolic targets for therapy.. Journal of Pathology. 2015
- Localization of MCT2 at peroxisomes is associated with malignant transformation in prostate cancer. Journal of Cellular and Molecular Medicine. 2015
- Lactate Transporters in the Context of Prostate Cancer Metabolism: What Do We Know?. International Journal of Molecular Sciences. 2014
- Nuclear ARRB1 induces pseudohypoxia and cellular metabolism reprogramming in prostate cancer. Embo Journal. 2014
- A lactate shuttle system between tumour and stromal cells is associated with poor prognosis in prostate cancer. BMC Cancer. 2014
- Monocarboxylate transporter 2 (MCT2) as putative biomarker in prostate cancer. Prostate. 2012
- Monocarboxylate transporter 4 (MCT4) and CD147 overexpression is associated with poor prognosis in prostate cancer.. BMC Cancer. 2011